SciELO - Scientific Electronic Library Online

 
vol.62 número1Genómica de rotavirus. Impacto en salud públicaPrevalencia de diabetes y descontrol glucémico en México: resultados de la Ensanut 2016 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Salud Pública de México

versión impresa ISSN 0036-3634

Resumen

MIRANDA-NOVALES, María Guadalupe  y  UNCAR NETWORK et al. Antimicrobial resistance and antibiotic consumption in Mexican hospitals. Salud pública Méx [online]. 2020, vol.62, n.1, pp.42-49.  Epub 28-Feb-2022. ISSN 0036-3634.  https://doi.org/10.21149/10543.

Objective:

To establish the current situation of antimicrobial resistance and antibiotic consumption in Mexican hospitals.

Materials and methods:

Antimicrobial susceptibility data from blood and urine isolates were collected. Defined daily dose (DDD) of antibiotic consumption/100 occupied beds (OBD) was calculated.

Results:

Study period: 2016 and 2017. Of 4 382 blood isolates, E. coli and K. pneumoniae were most frequently reported, with antimicrobial resistance >30% for most drugs tested, only for carbapenems and amikacin resistance were <20%. A. baumannii had antimicrobial resistance >20% to all drugs. Resistance to oxacillin in S. aureus was 20%. From 12 151 urine isolates, 90% corresponded to E. coli; resistance to ciprofloxacin, cephalosporins and trimethoprim/sulfamethoxazole was >50%, with good susceptibility to nitrofurantoin, amikacin and carbapenems. Global median antimicrobial consumption was 57.2 DDD/100 OB.

Conclusions:

This report shows a high antimicrobial resistance level in Gram-negative bacilli and provides an insight into the seriousness of the problem of antibiotic consumption.

Palabras llave : anti-bacterial agents; drug resistance, microbial; drug utilization.

        · resumen en Español     · texto en Inglés